It’s been frequently repeated that San Francisco, Boston, or New York are the best places to locate your business if you want to access seed and early-stage venture funding. While these three cities continue to represent a sizable portion of the deals, companies...
Ecosystem Development
Is Your Startup a Good Fit for SBIR/STTR Funding?
In 2024, life science startups continue to face challenges in accessing equity funding, particularly at the pre-seed/seed stage. Many turn to SBIR/STTR grants as a vital funding option. These grants provide crucial funding and additional benefits, such as honing...
NSF Research Funding to Build the American Bioeconomy – is it for you?
Executive Order 14081: Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy [1] in September 2022 marked a change in thinking about the U.S. bioeconomy. The order summarizes the situation perfectly: “The...
U.S. Strategy for Innovation – “Out Innovate With Everyone”
The National Advisory Council on Innovation and Entrepreneurship (NACIE) recently issued ten strategic recommendations for strengthening US entrepreneurship. The report highlights three critical areas: growing our future industries, accessing startup funding, and...
Building the Future Bioeconomy
This month's article discusses the challenges and solutions for establishing a robust U.S. bioeconomy. The President's Executive Order on innovation in biotechnology and biomanufacturing calls for agencies to submit reports on furthering societal goals related to...
What are Some Possible Outcomes of the FDA Modernization Act of 2022?
The Impact of the FDA Modernization Act 2.0 Late in December 2022, President Biden signed H.R. 2617 (117th): Consolidated Appropriations Act into law. While boringly titled, this Act contained the FDA Modernization Act 2.0, proposed initially as S.5002. While this...